Related Experiment Videos

Evolving considerations in the design and interpretation of phase I trials investigating gemcitabine based

Cornelius J McGinn¹

¹Department of Radiation Oncology, University of Michigan, Ann Arbor 48109-0010, USA.

Cancer Journal (Sudbury, Mass.)

|June 21, 2002

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Hypofractionated Conformal Radiotherapy with Concurrent Full-Dose Gemcitabine Versus Standard Fractionation Radiotherapy with Concurrent Fluorouracil for Unresectable Pancreatic Cancer: a Multi-Institution Experience.

Journal of gastrointestinal cancer·2016

Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2008

A phase II study of preoperative capecitabine and radiation therapy in patients with rectal cancer.

American journal of clinical oncology·2007

Long-term outcomes after radiotherapy for retroperitoneal and deep truncal sarcoma.

International journal of radiation oncology, biology, physics·2007

A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma.

Annals of surgical oncology·2006

Capecitabine and radiation therapy preceded and followed by combination chemotherapy in advanced pancreatic cancer.

International journal of radiation oncology, biology, physics·2005

See all related articles